Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Medical Device Management and Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.
Catheter Cardiovasc Interv. 2021 Aug 1;98(2):E171-E180. doi: 10.1002/ccd.29511. Epub 2021 Feb 6.
We investigated the gender difference in the 5-year outcome after percutaneous coronary intervention (PCI) using an unselected population data.
Sex-specific outcome after percutaneous coronary intervention (PCI) is not consistent among studies.
A total of 48,783 patients were enrolled from a Korean nationwide cohort of PCI in year 2011. Outcomes adjusted with age and propensity for clinical characteristics were compared. Primary outcome was 5-year cumulative incidence of all-cause death. Nonfatal major adverse clinical event (MACE) consisting of revascularization, shock, or stroke was also assessed.
In unadjusted analysis, women were older and had higher frequency of comorbidities including hypertension, hyperlipidemia, and diabetes compared to men (p < .001, all). Women had higher 5-year death risk than men (21.8 vs. 17.3%; hazard ratio [HR] 1.29, 95% confidential interval [CI] 1.23-1.34). In propensity score-matched analysis (N = 28,924), women had lower 5-year death risk (20.2 vs. 26.1%, HR 0.75, 95% CI 0.71-0.78). This lower death risk in women was consistent in subgroup analyses of age, risk factors, and clinical diagnosis including angina or acute myocardial infarction (p < .05, all).
Older age and more common comorbidities in women contributed to the apparent worse outcome after PCI in women. After adjusting these disadvantages, women had better outcome after PCI than men.
我们利用一项未选择人群的数据调查了经皮冠状动脉介入治疗(PCI)后 5 年的性别差异。
经皮冠状动脉介入治疗(PCI)后的性别特异性结果在不同研究中并不一致。
共纳入 2011 年韩国全国 PCI 队列中的 48783 例患者。对经年龄和倾向临床特征调整后的结局进行比较。主要结局为全因死亡的 5 年累积发生率。还评估了包括血运重建、休克或卒中等非致死性主要不良临床事件(MACE)。
在未调整分析中,女性比男性年龄更大,且合并症(包括高血压、高血脂和糖尿病)更常见(均 < 0.001)。女性的 5 年死亡风险高于男性(21.8%比 17.3%;风险比[HR] 1.29,95%置信区间[CI] 1.23-1.34)。在倾向评分匹配分析(N=28924)中,女性的 5 年死亡风险较低(20.2%比 26.1%,HR 0.75,95% CI 0.71-0.78)。在年龄、危险因素和包括心绞痛或急性心肌梗死在内的临床诊断的亚组分析中,女性的死亡风险较低(均 < 0.05)。
女性年龄更大且更常见合并症,导致女性 PCI 后结局明显较差。在调整这些劣势后,女性 PCI 后的结局优于男性。